Immunofluorescence assay for serologic diagnosis of SARS
- PMID: 15109430
- PMCID: PMC3322771
- DOI: 10.3201/eid1003.030493
Immunofluorescence assay for serologic diagnosis of SARS
Abstract
We evaluated an indirect immunofluorescence assay based on virus-infected cells for detecting anti-severe acute respiratory syndrome-associated coronavirus (SARS-CoV) immunoglobulin (Ig) G antibody. All confirmed SARS cases demonstrated seroconversion or fourfold rise in IgG antibody titer; no control was positive. Sensitivity and specificity of this assay were both 100%. Immunofluorescence assay can ascertain the status of SARS-CoV infection.
References
-
- World Health Organization. WHO issues a global alert about cases of atypical pneumonia. March 12, 2003. [accessed June 10, 2003]. Available from: http://www.who.int/csr/sars/archive/2003_03_12/en/print.html
-
- World Health Organization. Cumulative number of reported probable cases of SARS. [accessed Nov 27, 2003]. Available from: http://www.who.int/csr/sars/country/2003_06_30/en/print.html
-
- World Health Organization. Case definitions for surveillance of severe acute respiratory syndrome (SARS). Revised 1 May 2003. [accessed June 10, 2003]. Available from: http://www.who.int/csr/sars/casedefinition/en/print.html
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous